Excited to share our article about axial spondyloarthritis that was just published in JAMA! @jama.com #education #early_diagnosis #close_the_gap #axial_spondyloarthritis #axSpA #ankylosing_spondylitis #AS pubmed.ncbi.nlm.nih.gov/39630439/
December 5, 2024 at 4:40 AM
Excited to share our article about axial spondyloarthritis that was just published in JAMA! @jama.com #education #early_diagnosis #close_the_gap #axial_spondyloarthritis #axSpA #ankylosing_spondylitis #AS pubmed.ncbi.nlm.nih.gov/39630439/
As a #Disabled_Veteran with #Ankylosing_Spondylitis and #Thoracic_Radiculopathy being treated by the #VA it is very hard to manage a regular schedule on most days.
I am still waiting for my last C&P exam from the VA Disability folks so that they can bump me up the 100% where I should be.
I am still waiting for my last C&P exam from the VA Disability folks so that they can bump me up the 100% where I should be.
February 12, 2025 at 12:00 PM
As a #Disabled_Veteran with #Ankylosing_Spondylitis and #Thoracic_Radiculopathy being treated by the #VA it is very hard to manage a regular schedule on most days.
I am still waiting for my last C&P exam from the VA Disability folks so that they can bump me up the 100% where I should be.
I am still waiting for my last C&P exam from the VA Disability folks so that they can bump me up the 100% where I should be.
Lynk Pharmaceuticals Completes Patient Enrollment for Groundbreaking Ankylosing Spondylitis Trial#USA#Hangzhou#Lynk_Pharmaceuticals#Zemprocitinib#Ankylosing_Spondylitis
Lynk Pharmaceuticals Completes Patient Enrollment for Groundbreaking Ankylosing Spondylitis Trial
Lynk Pharmaceuticals has announced the successful completion of patient enrollment in a Phase III clinical trial evaluating its innovative drug, Zemprocitinib, for ankylosing spondylitis.
third-news.com
July 15, 2026 at 12:08 AM
Lynk Pharmaceuticals Completes Patient Enrollment for Groundbreaking Ankylosing Spondylitis Trial#USA#Hangzhou#Lynk_Pharmaceuticals#Zemprocitinib#Ankylosing_Spondylitis